The expanding demand for controlled immunological research and therapeutic design has spurred significant advances in recombinant signal molecule manufacture. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique functional roles, are frequently generated using various expression systems, including bacterial hosts, higher cell lines, and viral repli